Sign in
ASND Stock Price, Chart, Stats & News
Ascendis Pharma AS
Save
14.16B
Market cap
25.94x
Current P/E
14.27x
Forward P/E
ASND chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 86.28% |
Operating margin | -19.00% |
Pretax margin | -29.59% |
Net margin | -31.72% |
Effective tax rate | -7.21% |
ROA | -17.49% |
ROE | 127.54% |
D/E | -5.35x |
Interest coverage ratio | -0.86x |
ASND valuation
P/E | 25.94x |
P/S | 16.08x |
P/B | -70.91x |
P/CF | 225.56x |
P/FCF | 269.80x |
P/OCF | 225.56x |
PEG | -22.57x |
EV multiple | -139.87x |
About
Ascendis Pharma A/S is a biopharmaceutical enterprise dedicated to advancing therapeutic solutions for critical medical conditions that currently lack effective treatments. Its commercialized offering is SKYTROFA, a therapy prescribed for individuals suffering from growth hormone deficiency (GHD). The company boasts a robust development pipeline, featuring several TransCon-branded candidates.
Similar securities
Based on sector and market capitalization
Report issue